Despite new medication, cystic fibrosis often leads to permanent lung damage. Working with an international team, researchers ...

Perinatal dysfunction of innate immunity in cystic fibrosis.Sci. Transl. Med.17,eadk9145 (2025).DOI:10.1126/scitranslmed.adk9145 ...

Research co-led by University of Toronto researchers and Insilico Medicine has demonstrated the potential of quantum ...

Structural models suggest that these ... This approach mirrors strategies used in cystic fibrosis treatments, where targeted therapies address specific genetic mutations. Moreover, the precision ...

Cystic Fibrosis Mutation Analysis in Genetic Counseling Practice ... Increased Expression of RhoA in Epithelium and Smooth Muscle of Obese Mouse Models: Implications for Isoprenoid Control of Airway ...

In June, the Autism Research Project published the largest genetic study of autism so far, identifying 226 gene mutations that ... a diagnostic indicator of cystic fibrosis).

The biofilm model proposes that microbial cells ... CF is an autosomal recessive disease that is caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene that ...

The Massachusetts-based biotech plans to use the funds to push its candidates into mid-stage clinical trials in a space ...

In December, the FDA approved Alyftrek, a new once-daily pill for patients with cystic fibrosis caused by at least one of 303 possible mutations in their CFTR genes. Alyftrek's precursor ...

There are many misconceptions about CF. Learn the facts on our page, Dispelling Misconceptions About Cystic Fibrosis. In people with CF, mutations in the cystic fibrosis transmembrane conductance ...

Patients aged 6 to 11 years with cystic fibrosis receiving 24-week once-daily vanzacaftor/tezacaftor/deutivacaftor generally ...